greeksoup/ stock research
Stock research / US / S-1 filings / Core Specialty Insurance

Core Specialty Insurance S-1 filing, read

IPO prospectus · S-1 filed 16 November 2026 · 1 version on file · 288 printed pages read

Core Specialty Insurance Holdings, Inc. filed its S-1 with the SEC on 16 November 2026. This is what it says, read from the printed pages by code with no AI, in a fixed order: four questions about the business, and the price last. Every figure carries the page it was printed on.

Offer priceNot setnone in this filing yet cover
Revenue$2.2B9M 2026 -16% on the year before p.F-3
Revenue$3.4BFY2025 +5% on the year before p.F-37
Net result$85M9M 2026 p.F-5
Operating cash$440M9M 2026 p.F-5
Cash$262MSep 2026 p.F-2
Debt$397MSep 2026 p.F-2

What the business does

We are unafraid to expand rapidly into risks that we believe are attractive, or conversely, to pull back in markets failing to meet our return expectations. We will return capital to our stockholders if we believe there are insufficient opportunities meeting our targeted returns and at the discretion of our Board. We benefit from economies of scale through centralized capital, investment, reinsurance, risk, financial, and technology support. p.2

The five questions

Each reading with the chart behind it. Hover or tap a bar for its figure.

1 of 5Growing

Is revenue really growing?

Revenue grew 5% in FY25. Across the audited years it went from $2.5B in FY23 to $3.4B in FY25. The filing reports no segment split, so growth cannot be checked business by business.

$3.4BRevenue, FY25 p.F-37
Revenue by year, then year to date p.F-37FY2023 · Revenue: $2.5B$2.5BFY2023FY2024 · Revenue: $3.2B$3.2BFY2024FY2025 · Revenue: $3.4B$3.4BFY20253M 2025 · Revenue: $855M$855M3M 20259M 2025 · Revenue: $2.6B$2.6B9M 20253M 2026 · Revenue: $690M$690M3M 20269M 2026 · Revenue: $2.2B$2.2B9M 2026
$ millions as printed; hover a bar for its figure
2 of 5Partly read

Does it fund its own growth?

Capex could not be read, so free cash flow is not shown. In 9M ’26 operations produced $440M, and $12M came in from shareholders and lenders.

$440MOperating cash flow, 9M ’26 p.F-5
Cash in from operations, cash out on capital spending 9M 2025 · Operating cash flow: $612M9M 20259M 2026 · Operating cash flow: $440M9M 2026
Operating cash flowCapital spendingFree cash flow
Free cash flow = operating cash flow minus capital spending
3 of 5Net debt

Is the debt sane?

Debt is above cash: read the maturity schedule. At Sep ’26 the balance sheet held $262M of cash against $397M of debt.

$135MNet debt, Sep ’26 p.F-2
Cash, debt and equity on the balance sheet p.F-2FY2025 · Cash: $275M$275MFY2025 · Debt: $372M$372MFY2025 · Equity: $1.4B$1.4BFY2025Sep 2026 · Cash: $262M$262MSep 2026 · Debt: $397M$397MSep 2026 · Equity: $1.4B$1.4BSep 2026
CashDebtEquity
At each year end, and the latest balance sheet date
4 of 5Cash in line

Does the profit show up as cash?

In 9M ’26, reported result $85M against $440M of operating cash. The largest non-cash item in 9M ’26 was “premiums receivable”, −$587M.

$85M / $440MResult / op. cash, 9M ’26 p.F-5
The result against the cash operations produced p.F-59M 2025 · Net result: $135M9M 2025 · Operating cash flow: $612M9M 20259M 2026 · Net result: $85M9M 2026 · Operating cash flow: $440M9M 2026
Net result, profitNet result, lossOperating cash flow
5 of 5Not set

Only then: is the price sane?

No price in this filing yet, so no multiple can be computed. That is normal before the roadshow. Whatever the price, it will sit on $3.4B of FY25 revenue.

Not setOffer price cover
Control, in the filing's words
  • Who elects the boardTherefore, stockholders holding a majority in voting power of the shares of our stock entitled to vote generally in the election of directors will be able to elect all of our directors. p.160

The holders the filing names p.156

HolderGroup
Corinthian DF Holdings, LPGreater than 5% and Selling Stockholders
Cavello Bay Reinsurance LimitedGreater than 5% and Selling Stockholders
Aquiline Financial Services Fund IV L.PGreater than 5% and Selling Stockholders
David P. Delaney JrGreater than 5% and Selling Stockholders
Timothy D. DelaneyGreater than 5% and Selling Stockholders
Joseph E. (“Jeff”) ConsolinoNamed Executive Officers and Directors
Evan M. CabatNamed Executive Officers and Directors
William C. VensNamed Executive Officers and Directors
Robert F. KuzloskiNamed Executive Officers and Directors
Jeffrey C. WanamakerNamed Executive Officers and Directors
Cathryn Crites WarnerNamed Executive Officers and Directors
All executive officers and directors as a group (persons)Named Executive Officers and Directors

The filing has not printed these holders' share counts or percentages yet. They are blank in this version.

Key figures, as printed

From the statements of operations and cash flows

$ millionFY2023FY2024FY20253M 20259M 20253M 20269M 2026Page
Revenue2,4803,2173,371p.F-37
Revenue, year to date8552,5536902,158p.F-3
Net income (loss)13584.9p.F-5
Operating cash flow612440p.F-5

From the balance sheet

$ millionFY2025Sep 2026Page
Cash275262p.F-2
Debt
current plus non-current lines, leases as the filing groups them
372397p.F-2

The financial statements, as printed

Every line in the filing's own order and words. Switch between $ million and $ billion in the table's corner; the column headings stay in view as you scroll down.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) p.F-3 p.F-4 p.F-37

$ millionFY2023FY2024FY20253M 20259M 20253M 20269M 2026
REVENUES
Net premiums earned2,2972,9683,0737742,3266822,037
Net investment income98.914617644.612952.4150
Net realized and unrealized investment gains (losses)39.726.439.516.539.0-68.5-105
Fees and commission income44.176.582.020.659.524.076.6
Other income (loss)0.7-0.30.1-0.1-0.10.10.0
Total revenues2,4803,2173,3718552,5536902,158
LOSSES AND EXPENSES
Net incurred losses and loss adjustment expenses1,6852,0802,1285331,6334381,311
Acquisition costs, including amortization of value of business acquired411568626162470161474
General and administrative expenses21329833887.525576.1238
Interest expense13.925.421.75.616.55.315.0
Provision for legal settlement0.00.025.00.00.00.0-7.7
Loss on abandonment of software assets12.28.172.0
Corporate and other expenses12.016.310.81.46.911.318.7
Total losses and expenses2,3472,9963,2227892,3816922,049
INCOME (LOSS) BEFORE INCOME TAXES13322114966.2173-1.7108
Income tax expense (benefit)16.754.229.814.537.4-0.323.4
NET INCOME (LOSS)11616711951.7135-1.484.9
Dividends on preferred stock4.64.66.31.64.71.64.7
NET INCOME (LOSS) AVAILABLE (ATTRIBUTABLE) TO COMMON AND PREFERRED STOCKHOLDERS11216211350.1130-3.080.2
Net income allocated to preferred stockholders16.223.416.17.218.70.011.4
NET INCOME (LOSS) AVAILABLE (ATTRIBUTABLE) TO COMMON STOCKHOLDERS95.513996.542.9112-3.068.8
Net income (loss) available (attributable) to common stockholders per share
Basic per share, $9.6113.909.584.2511.09-0.296.80
Diluted per share, $9.5613.829.534.2411.05-0.296.76
Weighted average shares outstanding
Basic shares, millions9,939,1629,998,81310,079,58710,092,37510,074,77510,120,12910,111,922
Diluted shares, millions9,986,84210,059,98210,126,77610,117,24910,112,46410,120,12910,168,104
MEZZANINE EQUITY
Preferred Stock
Balance, beginning of period165165165165
Issuance of shares0.00.00.00.0
TOTAL MEZZANINE EQUITY165165165165
STOCKHOLDERS’ EQUITY
Common Stock
Balance, beginning of period0.10.10.10.1
Issuance of shares0.00.00.00.0
Share awards granted/vested0.00.00.00.0
Balance, end of period0.10.10.10.1
Treasury Stock
Balance, beginning of period0.00.0-4.20.0
Repurchase of common shares0.00.00.0-4.2
Balance, end of period0.00.0-4.2-4.2
Additional Paid-in Capital
Balance, beginning of period1,0161,0101,0251,020
Issuance of shares0.01.00.00.0
Share awards granted/vested1.78.11.58.2
Repurchase of common shares-0.8-2.10.0-1.6
Balance, end of period1,0171,0171,0261,026
Accumulated Other Comprehensive Income
Balance, end of period0.00.00.00.0
Retained Earnings
Balance, beginning of period310230426343
Dividends-1.6-4.7-1.6-4.7
Net income51.7135-1.484.9
Balance, end of period360360423423
TOTAL STOCKHOLDERS’ EQUITY1,3781,3781,4451,445
TOTAL MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY1,5431,5431,6101,610
Common Shares
Common shares issued, beginning of period10,121,39210,027,18310,197,21110,127,370
Issuance of common stock0.08,2710.00.0
Stock awards and restricted stock units issued and vested, net of shares withheld5,97891,9160.069,841
Common shares issued, end of period10,127,37010,127,37010,197,21110,197,211
Treasury shares-33,451-33,451-77,082-77,082
Common shares outstanding, end of period10,093,91910,093,91910,120,12910,120,129

CONDENSED CONSOLIDATED BALANCE SHEET p.F-2 p.F-36

$ millionFY2024FY2025Sep 2026
ASSETS
Fixed maturities, trading, at fair value3,3533,9734,288
Other investments47.760.478.9
Cash and cash equivalents234275262
Restricted cash and cash equivalents9.07.025.6
Total investments, cash and cash equivalents3,6434,3154,655
Premiums receivable (net of credit allowance of $3.7 and $3.6)8168301,417
Net deferred tax asset56.640.353.5
Prepaid reinsurance premiums310362653
Recoverables from reinsurers
Property and casualty insurance (net of credit allowance of $4.7 and $7.4)1,5991,8072,056
Life and other accident and health insurance (net of credit allowance of $0.0 and $0.3)94.585.783.4
Fixed annuities and life18.815.814.1
Deferred acquisition costs and value of business acquired226240279
Goodwill86.089.889.8
Intangible assets with definite lives62.462.057.0
Other assets414414424
TOTAL ASSETS7,3268,2629,781
LIABILITIES
Insurance reserves
Losses and loss adjustment expenses3,5224,2394,722
Life and other accident and health future policy benefits94.885.783.4
Policyholders’ account balances18.815.814.1
Unearned premiums1,4391,5081,995
Reinsurance balances payable273294716
Funds withheld liabilities22.016.715.0
Long-term debt372372397
Other liabilities178203229
TOTAL LIABILITIES5,9216,7348,170
MEZZANINE EQUITY
Preferred stock, par value of $0.01, 2,000,000 shares authorized, 1,684,129 shares issued and outstanding165165165
STOCKHOLDERS’ EQUITY
Common stock, par value of $0.01, 11,000,000 shares authorized, 2025: 10,127,370 shares issued; 10,093,723 outstanding, 2024: 10,027,183 shares issued; 10,010,273 outstanding0.10.10.1
Treasury stock, par value of $0.01 (2025: 33,647; 2024: 16,910)0.00.0-4.2
Additional paid-in capital1,0101,0201,026
Retained earnings230343423
TOTAL STOCKHOLDERS’ EQUITY1,2401,3621,445
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY7,3268,2629,781

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) p.F-5 p.F-39

$ millionFY2023FY2024FY20259M 20259M 2026
OPERATING ACTIVITIES
Net income11616711913584.9
Adjustments to reconcile net income to net cash flows provided by operating activities
Share compensation expense6.59.310.37.37.3
Realized (gains) losses on sale of investments1.0-0.1-2.4-2.50.1
Unrealized (gains) losses on trading securities-43.1-15.2-31.8-31.2121
Unrealized gains on other investments2.4-11.1-5.3-5.3-16.1
Capitalized interest income on other investments-0.9-1.0-1.1-0.8-0.9
Depreciation and other amortization26.642.148.736.537.7
Changes in
Reinsurance recoverables93.2-262-196-225-245
Insurance claims and reserves345802704773479
Reinsurance balances payable-47.736.221.0172422
Unearned premiums30518.7-19.7296487
Premiums receivable-1261.919.5-427-587
Prepaid reinsurance premiums-78.76.6-52.5-103-290
Funds withheld liabilities-6.7-22.3-5.3-4.5-1.7
Other operating assets and liabilities-27.3-56.98.0-9.3-57.1
Net cash flows provided by operating activities566716617612440
INVESTING ACTIVITIES
Acquisitions, net of cash acquired-78.413643.343.20.0
Sales and maturities of trading securities1776871,037720812
Purchases of trading securities-528-1,622-1,626-1,134-1,248
Net repayment (funding) of credit arrangements-5.00.00.5
Net funding of credit arrangements-8.5-0.8
Sales of preferred stock and other investments0.00.04.14.10.0
Purchases of preferred stock and other investments-1.0-5.8-8.1-7.9-0.7
Purchases of fixed assets-78.2-71.4-17.0-66.6-8.6
Net cash flows used in investing activities-513-876-566-450-446
FINANCING ACTIVITIES
Repurchase of shares-0.6-0.8-2.1-2.1-5.8
Cash dividends paid-4.6-4.6-6.3-4.7-4.7
Payment of contingent consideration0.0-13.6-3.0-4.1-2.6
Borrowings under revolving credit facility1800.00.00.025.0
Net cash flows provided by (used in) financing activities175-19.0-11.4-10.911.9
Net increase in cash, cash equivalents and restricted cash227-17939.31516.0
Cash, cash equivalents and restricted cash, beginning of period195422242242282
Cash, cash equivalents and restricted cash, end of period422242282394288
Supplemental Cash Flow Information
Income taxes paid, net of refunds14.553.733.733.015.7
Interest paid13.725.721.616.715.3
Reconciliation to Consolidated Balance Sheet
Reconciliation to Condensed Consolidated Balance Sheet
Cash and cash equivalents408234275368262
Restricted cash and cash equivalents13.69.07.025.625.6
Cash, cash equivalents and restricted cash422242282394288

Stock pay and commitments

Commitments by year p.472025 · Due: $2.9B$2.9B2025
Contractual obligations (all lines), $ as printed

The people

Executive officers and directors as the filing lists them.

NameRoleAgePage
Evan M. CabatExecutive Vice President and Chief Financial Officer42p.123
Michael L. PowellExecutive Vice President and General Counsel47p.123
Jeffrey C. WanamakerChief Underwriting Officer60p.123
Cathryn C. WarnerChief Operating Officer63p.123
Donald D. LarsonVice Chairman and Director75p.123
Dominic J. AddessoDirector73p.123
Sally Pope DavisDirector69p.123
M. Steven DeCarloDirector68p.123
David P. Delaney Jr.Director74p.123
Matthew C. EbbelDirector47p.123
Patrick GordonDirector37p.123
David NiDirector43p.123
Paul J. O’SheaDirector68p.123
Bart van der VlugtDirector32p.123

The offer and the flags

The offer
Listing
New York Stock Exchange cover
Ticker
CORE cover
Lead underwriters
not found
Lock-up
180 days p.170
Employees
not found
Risk headings
47
Auditor
Ernst & Young LLP p.177
  • Use of proceedsThe selling stockholders will receive all of the net proceeds from the sale of shares of our common stock in this offering. p.37
  • Lock-upMorgan Securities LLC and Goldman Sachs & Co. LLC for a period of 180 days after the date of this prospectus, other than the shares of our common stock to be sold in this offering. p.170
What the filing flags · 4 in all
  • TrustMaterial weakness in internal control p.30
  • TrustGoing-concern doubt p.F-7
  • SilenceNo price in this filing cover
  • NumbersPre-IPO funding turns into shares at the offering p.v p.11 p.39 p.156 p.158 p.164

Patterns from past IPO reads that fired on this filing. Each is a page to read, not a verdict.

The risks it lists first

The filing lists 47 risk headings. The first 8, in its own words:

  • Our results of operations could be adversely impacted by catastrophes, both natural and man-made, pandemics, severe weather conditions or climate change. p.14
  • Our success depends primarily on our ability to underwrite risks effectively and adequately price the risks we insure. p.15
  • Our limited operating history may make it difficult to evaluate our current business and future prospects. p.15
  • The effects of emerging claim and coverage issues in our business and social inflation are uncertain, and we face risks associated with litigation. p.15
  • Our results of operations and revenues may fluctuate as a result of many factors, including cyclical changes in the insurance industry such as the current soft market. p.16
  • We depend on a few brokers for a large portion of our insurance revenues and the loss of business provided by any one of those brokers could adversely affect us. p.16
  • We are subject to credit risk with regard to our reinsurance counterparties. p.17
  • Volatility in crop prices, as a result of weather conditions or other events, could adversely impact our results of operations. p.17

When did Core Specialty Insurance file its S-1?

Core Specialty Insurance filed its first registration statement, an S-1, on 16 November 2026.

What does Core Specialty Insurance's S-1 say about revenue?

Revenue grew 5% in FY25. Across the audited years it went from $2.5B in FY23 to $3.4B in FY25. The filing reports no segment split, so growth cannot be checked business by business.

Who controls Core Specialty Insurance after the IPO?

The filing lists Corinthian DF Holdings, LP, Cavello Bay Reinsurance Limited and Aquiline Financial Services Fund IV L.P among its holders of 5% or more. Their share counts and voting percentages are blank in this version of the filing.

The filing itself

Read 22 November 2026, 17:17 from SEC EDGAR. Information from a public filing, not advice.